ArticleHaematologica2018

Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease.

Joséphine Muller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.